EP3827845
And-CD38 mótefnissamsetningar til notkunar undir húð og notkun þeirra
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
1.11.2016EP published:
30.3.2022EP application number:
20215879.6
EP translation filed:
3.5.2022Grant published:
15.6.2022EPO information:
European Patent Register
Max expiry date:
31.10.2036Expiry date:
31.10.2026Next due date:
30.11.2026
Title in English:
SUBCUTANEOUS FORMULATIONS OF ANTI-CD38 ANTIBODIES AND THEIR USESLanguage of the patent:
English
Timeline
Today
1.11.2016EP application
30.3.2022EP Publication
3.5.2022Translation submitted
15.6.2022Registration published
31.10.2026Expires
Owner
Name:
Janssen Biotech, Inc.Address:
800/850 Ridgeview Drive, Horsham, PA 19044, US
Inventor
Name:
JANSSON, RichardAddress:
Doylestown, Pennsylvania 18902, US
Name:
KUMAR, VineetAddress:
Spring House, Pennsylvania 19477, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562250016 PDate:
3.11.2015Country:
US
Classification
Categories:
A61K 39/395, A61K 31/4439, A61K 31/198, A61K 31/573, A61K 31/69, C07K 16/28, A61K 9/10, A61K 47/12, A61K 47/20, A61K 47/22, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 6.10.2022
Expires: 31.10.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 26.10.2023
Expires: 31.10.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 8.10.2024
Expires: 31.10.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 4.11.2025
Expires: 31.10.2026
Payer: Árnason Faktor ehf.